Ayurcann Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05476A1012
CAD
0.03
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Dec 24

  • INTEREST(HY) At CAD 0.39 MM has Grown at 27.97%
  • OPERATING CASH FLOW(Y) Lowest at CAD -1.03 MM
  • ROCE(HY) Lowest at -336.81%
2

Risky - Negative EBITDA

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 7 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.93

stock-summary
Return on Equity

370.52%

stock-summary
Price to Book

-6.81

Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
20.0%
0%
20.0%
3 Years
-40.0%
0%
-40.0%
4 Years
-82.35%
0%
-82.35%
5 Years
0%
0%
0.0%

Ayurcann Holdings Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
98.41%
EBIT Growth (5y)
-208.45%
EBIT to Interest (avg)
-2.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
11.89
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.73%
ROE (avg)
6.99%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-6.81
EV to EBIT
-2.82
EV to EBITDA
-4.59
EV to Capital Employed
7.75
EV to Sales
0.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-274.99%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 1.33% vs -9.64% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -500.00% vs 75.00% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.60",
          "val2": "7.50",
          "chgp": "1.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "0.30",
          "chgp": "-166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.10",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-51.20%",
          "val2": "10.50%",
          "chgp": "-6.17%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 101.60% vs 32.98% in Jun 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is 24.53% vs -70.97% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.20",
          "val2": "12.50",
          "chgp": "101.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-4.60",
          "chgp": "56.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.00",
          "val2": "-5.30",
          "chgp": "24.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-129.20%",
          "val2": "-427.80%",
          "chgp": "29.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
7.60
7.50
1.33%
Operating Profit (PBDIT) excl Other Income
-0.20
0.30
-166.67%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-0.10
-500.00%
Operating Profit Margin (Excl OI)
-51.20%
10.50%
-6.17%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is 1.33% vs -9.64% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -500.00% vs 75.00% in Dec 2024

Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
25.20
12.50
101.60%
Operating Profit (PBDIT) excl Other Income
-2.00
-4.60
56.52%
Interest
0.70
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.00
-5.30
24.53%
Operating Profit Margin (Excl OI)
-129.20%
-427.80%
29.86%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2024 is 101.60% vs 32.98% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2024 is 24.53% vs -70.97% in Jun 2023

stock-summaryCompany CV
About Ayurcann Holdings Corp. stock-summary
stock-summary
Ayurcann Holdings Corp.
Pharmaceuticals & Biotechnology
Canada Coal Inc. is a Canada-based junior resource mining company. The Company's principal business is the acquisition and exploration of coal properties in Nunavut, Canada. Its coal licenses are located on Ellesmere Island and Axel Heiberg Islands, Nunavut Territory, Canada. The project consists of 75 coal licenses geographically distributed as nine discrete exploration areas occupying a total of 989,521 hectares. The exploration areas consist of Fosheim Peninsula, Sor Fiord/Stenkul Fiord, Strathcona Fiord, Vesle Fiord/South Fosheim, May Point, Bache Peninsula, Li Fiord, Good Friday Bay and Mokka Fiord. The licenses are held by the Company's two subsidiaries: 5200 Nunavut Ltd. and Canadian Sovereign Coal Corp. The Company is at the early stages of exploration on its projects and has not generated revenues from its operations.
Company Coordinates stock-summary
Company Details
5213 Durie Road , MISSISSAUGA ON : L5M-2C6
stock-summary
Tel: 1 905 8138408
stock-summary
Registrar Details